B 细胞急性淋巴细胞白血病治疗性单克隆抗体研发的最新进展 Recent advances in monoclonal antibody development for treatment of B-cell acute lymphoblastic leukemia. PubMed 2025/06/02 发表Leuk LymphomaQ3 · IF 2.1(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T技术:双特异性抗体急性淋巴细胞白血病淋巴瘤
识别 CAR-T 细胞疗效与安全性的调节因素:系统综述与个体患者数据荟萃分析 Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis. PubMed 2025/04/08 发表Transfus Med RevQ2 · IF 3(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T血液系统恶性肿瘤地区:其他
急性淋巴细胞白血病(ALL)对 FDA 批准靶向治疗和免疫治疗反应的预测 Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL). PubMed 2024/08/05 发表Curr Treat Options OncolQ1 · IF 5.8(JCR 2025) 人群:儿童人群:成人靶点:CD19靶点:CD20靶点:CD22急性淋巴细胞白血病
靶向人 CD22 的治疗活性纳米抗体 CAR 的发现与临床前开发 Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22. PubMed 2024/02/13 发表Mol Ther OncolQ1 · IF 8.5(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T淋巴瘤地区:其他
结直肠癌和浸润性乳腺癌中 CAR-T 细胞治疗的临床新视角与挑战 Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. PubMed 2023/08/11 发表Arch Immunol Ther Exp (Warsz)Q3 · IF 3.2(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T血液系统恶性肿瘤结直肠癌乳腺癌